Literature DB >> 19624525

Association of G-protein-coupled receptor 154 with asthma and total IgE in a population of the Caribbean coast of Colombia.

C Vergara1, S Jiménez, N Acevedo, B Martínez, D Mercado, L Gusmão, N Rafaels, T Hand, K C Barnes, L Caraballo.   

Abstract

BACKGROUND: G protein-coupled receptor 154 was described as an asthma susceptibility gene by positional cloning. It has been subsequently associated with asthma and other inflammatory diseases in several populations with different ethnic origin. Replication of associations adds reliability to these findings.
OBJECTIVE: To analyze the association of G protein-coupled receptor 154 with asthma and total and mite-specific IgE levels in a population of the Caribbean Coast of Colombia.
METHODS: We genotyped seven single nucleotide proteins (SNPs) in GPR154 in 475 asthmatics, 394 controls and 116 families from Cartagena, Colombia using either SnaPshot or TaqMan. Total and specific IgE against Blomia tropicalis and Dermatophagoides pteronyssinus were determined by ELISA. Hardy-Weinberg equilibrium was assessed and case-control and family-based analyses were performed to evaluate the association between the SNPs and their haplotypes and asthma and IgE. Association analyses in the case-control dataset were corrected by population stratification using 52 ancestry informative markers.
RESULTS: Allelic distribution was similar to that described in other populations. Two SNPs were associated with the same direction of the effect in both datasets. Allele A of Hopo546333 was protective for asthma (case-control OR: 0.42; 95% CI: 0.17-0.99, P=0.042; P=0.043; families Z score=-2,236; P=0.025). Similarly, allele C of rs740347 conferred low risk for asthma (OR: 0.44; 95% CI: 0.28-0.70, P=0.00017; Pc=0.00037) and total IgE (OR: 0.29; 95% CI: 0.09-0.88, P=0.015; Pc=0.030) in the case-control study and families (Z score=-3.207, P=0.0013; Z score=-3.182, P=0.0014, respectively). Haplotype CCAGGT was associated with total IgE (OR: 1.76; 95% CI: 1.14-2.71, P=0.006, Pc=0.007) in the case-controls group and CGCGGT with both phenotypes (P=0.044 and P=0.032, respectively) in families. Neither SNPs nor haplotypes were associated with levels of mite-specific IgE.
CONCLUSIONS: Our findings in a sample of asthmatics from Colombia suggest a relevant role of G protein-coupled receptor 154 in the pathogenesis of asthma and allergy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19624525     DOI: 10.1111/j.1365-2222.2009.03311.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  10 in total

Review 1.  Developments in the field of allergy in 2009 through the eyes of Clinical and Experimental Allergy.

Authors:  H W Chu; C M Lloyd; W Karmaus; P Maestrelli; P Mason; G Salcedo; J Thaikoottathil; A J Wardlaw
Journal:  Clin Exp Allergy       Date:  2010-11       Impact factor: 5.018

2.  Neither self-reported ethnicity nor declared family origin are reliable indicators of genomic ancestry.

Authors:  Bruna Ribeiro de Andrade Ramos; Maria Paula Barbieri D'Elia; Marcos Antônio Trindade Amador; Ney Pereira Carneiro Santos; Sidney Emanuel Batista Santos; Erick da Cruz Castelli; Steven S Witkin; Hélio Amante Miot; Luciane Donida Bartoli Miot; Márcia Guimarães da Silva
Journal:  Genetica       Date:  2016-03-17       Impact factor: 1.082

Review 3.  Pharmacology, Physiology and Genetics of the Neuropeptide S System.

Authors:  Rainer K Reinscheid; Chiara Ruzza
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-23

4.  Multiple polymorphisms affect expression and function of the neuropeptide S receptor (NPSR1).

Authors:  Francesca Anedda; Marco Zucchelli; Danika Schepis; Anna Hellquist; Lucia Corrado; Sandra D'Alfonso; Adnane Achour; Gerald McInerney; Alejandro Bertorello; Mikael Lördal; Ragnar Befrits; Jan Björk; Francesca Bresso; Leif Törkvist; Jonas Halfvarson; Juha Kere; Mauro D'Amato
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

5.  Neuropeptide S (NPS) variants modify the signaling and risk effects of NPS Receptor 1 (NPSR1) variants in asthma.

Authors:  Nathalie Acevedo; Sini Ezer; Simon Kebede Merid; Vincent D Gaertner; Cilla Söderhäll; Mauro D'Amato; Michael Kabesch; Erik Melén; Juha Kere; Ville Pulkkinen
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

6.  DNA methylation in the Neuropeptide S Receptor 1 (NPSR1) promoter in relation to asthma and environmental factors.

Authors:  Lovisa E Reinius; Anna Gref; Annika Sääf; Nathalie Acevedo; Maaike Joerink; Maciej Kupczyk; Mauro D'Amato; Anna Bergström; Erik Melén; Annika Scheynius; Sven-Erik Dahlén; Göran Pershagen; Cilla Söderhäll; Juha Kere
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

7.  Interaction between retinoid acid receptor-related orphan receptor alpha (RORA) and neuropeptide S receptor 1 (NPSR1) in asthma.

Authors:  Nathalie Acevedo; Annika Sääf; Cilla Söderhäll; Erik Melén; Jami Mandelin; Christina Orsmark Pietras; Sini Ezer; Piia Karisola; Johanna Vendelin; Gustav Boije af Gennäs; Jari Yli-Kauhaluoma; Harri Alenius; Erika von Mutius; Gert Doekes; Charlotte Braun-Fahrländer; Josef Riedler; Marianne van Hage; Mauro D'Amato; Annika Scheynius; Göran Pershagen; Juha Kere; Ville Pulkkinen
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

8.  Investigating highly replicated asthma genes as candidate genes for allergic rhinitis.

Authors:  Anand Kumar Andiappan; Daniel Nilsson; Christer Halldén; Wang De Yun; Torbjörn Säll; Lars Olaf Cardell; Chew Fook Tim
Journal:  BMC Med Genet       Date:  2013-05-10       Impact factor: 2.103

9.  A genome-wide association study of total serum and mite-specific IgEs in asthma patients.

Authors:  Jeong-Hyun Kim; Hyun Sub Cheong; Jong Sook Park; An-Soo Jang; Soo-Taek Uh; Yong-Hoon Kim; Mi-Kyeong Kim; Inseon S Choi; Sang Heon Cho; Byoung Whui Choi; Joon Seol Bae; Choon-Sik Park; Hyoung Doo Shin
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

10.  Neuropeptide S receptor 1 (NPSR1) activates cancer-related pathways and is widely expressed in neuroendocrine tumors.

Authors:  V Pulkkinen; S Ezer; L Sundman; J Hagström; S Remes; C Söderhäll; D Greco; G Dario; C Haglund; J Kere; J Arola
Journal:  Virchows Arch       Date:  2014-06-12       Impact factor: 4.064

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.